Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 4,357 $ 2,815
Trading marketable securities 500 7,611
Prepaid expenses and other current assets 129 554
Total Current Assets 4,986 10,980
Operating lease right-of-use assets 108 21
Intangible asset 2,039 2,039
Other assets 3 3
TOTAL ASSETS 7,136 13,043
Current Liabilities    
Accounts payable and accrued liabilities 627 1,238
Due to related parties 36 30
Operating lease liabilities - current portion 34 23
Total Current Liabilities 697 1,291
Operating lease liabilities 78 0
TOTAL LIABILITIES 775 1,291
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized, as of September 30, 2024 and December 31, 2023 3,227,700 and 3,188,959 shares issued and outstanding, as of September 30, 2024 and December 31, 2023 3 3
Additional paid-in capital 52,934 52,262
Accumulated deficit (46,358) (40,310)
Accumulated other comprehensive loss (218) (203)
TOTAL STOCKHOLDERS' EQUITY 6,361 11,752
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 7,136 $ 13,043